nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—UGT1A1—Mycophenolic acid—systemic scleroderma	0.0781	0.11	CbGbCtD
Estradiol—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.0519	0.0727	CbGbCtD
Estradiol—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.0436	0.0612	CbGbCtD
Estradiol—ABCG2—Leflunomide—systemic scleroderma	0.0388	0.0545	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—systemic scleroderma	0.0372	0.0522	CbGbCtD
Estradiol—ABCC10—Methotrexate—systemic scleroderma	0.0372	0.0522	CbGbCtD
Estradiol—AOX1—Methotrexate—systemic scleroderma	0.0352	0.0494	CbGbCtD
Estradiol—CYP2C8—Mometasone—systemic scleroderma	0.0321	0.045	CbGbCtD
Estradiol—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0302	0.0424	CbGbCtD
Estradiol—SLCO1A2—Prednisone—systemic scleroderma	0.0256	0.0359	CbGbCtD
Estradiol—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.024	0.0337	CbGbCtD
Estradiol—ALB—Captopril—systemic scleroderma	0.021	0.0295	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—systemic scleroderma	0.0208	0.0292	CbGbCtD
Estradiol—SLC22A11—Methotrexate—systemic scleroderma	0.0192	0.027	CbGbCtD
Estradiol—CYP1A2—Pentoxifylline—systemic scleroderma	0.0168	0.0235	CbGbCtD
Estradiol—ALB—Mycophenolate mofetil—systemic scleroderma	0.0165	0.0232	CbGbCtD
Estradiol—CYP1A2—Leflunomide—systemic scleroderma	0.016	0.0225	CbGbCtD
Estradiol—ABCB1—Lisinopril—systemic scleroderma	0.0147	0.0206	CbGbCtD
Estradiol—CYP2C9—Leflunomide—systemic scleroderma	0.0144	0.0202	CbGbCtD
Estradiol—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0133	0.0186	CbGbCtD
Estradiol—ALB—Prednisone—systemic scleroderma	0.0132	0.0185	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—systemic scleroderma	0.0128	0.018	CbGbCtD
Estradiol—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0128	0.0179	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—systemic scleroderma	0.0121	0.017	CbGbCtD
Estradiol—SLC22A8—Methotrexate—systemic scleroderma	0.0112	0.0157	CbGbCtD
Estradiol—ABCB1—Captopril—systemic scleroderma	0.011	0.0154	CbGbCtD
Estradiol—ABCG2—Methotrexate—systemic scleroderma	0.00962	0.0135	CbGbCtD
Estradiol—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00865	0.0121	CbGbCtD
Estradiol—CYP2C19—Prednisone—systemic scleroderma	0.00857	0.012	CbGbCtD
Estradiol—ABCB1—Prednisone—systemic scleroderma	0.00692	0.0097	CbGbCtD
Estradiol—CYP2C9—cardial valve—systemic scleroderma	0.00687	0.139	CbGeAlD
Estradiol—ALB—Methotrexate—systemic scleroderma	0.00663	0.0093	CbGbCtD
Estradiol—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00518	0.00727	CbGbCtD
Estradiol—CYP3A4—Prednisone—systemic scleroderma	0.00414	0.00581	CbGbCtD
Estradiol—ABCB1—Methotrexate—systemic scleroderma	0.00347	0.00487	CbGbCtD
Estradiol—ESRRB—tendon—systemic scleroderma	0.00295	0.0595	CbGeAlD
Estradiol—GPER1—smooth muscle tissue—systemic scleroderma	0.00269	0.0544	CbGeAlD
Estradiol—FABP2—digestive system—systemic scleroderma	0.00235	0.0474	CbGeAlD
Estradiol—GPER1—tendon—systemic scleroderma	0.00202	0.0409	CbGeAlD
Estradiol—NR1I2—digestive system—systemic scleroderma	0.00178	0.0359	CbGeAlD
Estradiol—ESR1—blood vessel—systemic scleroderma	0.0011	0.0222	CbGeAlD
Estradiol—ESRRA—digestive system—systemic scleroderma	0.000989	0.02	CbGeAlD
Estradiol—ESRRA—tendon—systemic scleroderma	0.000941	0.019	CbGeAlD
Estradiol—SLCO1B3—lung—systemic scleroderma	0.000851	0.0172	CbGeAlD
Estradiol—ESRRA—lung—systemic scleroderma	0.000826	0.0167	CbGeAlD
Estradiol—ESR2—connective tissue—systemic scleroderma	0.000822	0.0166	CbGeAlD
Estradiol—SLC22A11—digestive system—systemic scleroderma	0.000811	0.0164	CbGeAlD
Estradiol—SHBG—connective tissue—systemic scleroderma	0.000799	0.0161	CbGeAlD
Estradiol—ESR2—smooth muscle tissue—systemic scleroderma	0.000752	0.0152	CbGeAlD
Estradiol—UGT1A1—digestive system—systemic scleroderma	0.000708	0.0143	CbGeAlD
Estradiol—SLC22A2—digestive system—systemic scleroderma	0.000705	0.0142	CbGeAlD
Estradiol—SLCO4A1—digestive system—systemic scleroderma	0.000669	0.0135	CbGeAlD
Estradiol—SLC22A3—connective tissue—systemic scleroderma	0.000659	0.0133	CbGeAlD
Estradiol—CYP1B1—connective tissue—systemic scleroderma	0.000606	0.0122	CbGeAlD
Estradiol—SLC22A3—smooth muscle tissue—systemic scleroderma	0.000603	0.0122	CbGeAlD
Estradiol—ESR2—digestive system—systemic scleroderma	0.000594	0.012	CbGeAlD
Estradiol—SLCO1B1—digestive system—systemic scleroderma	0.000589	0.0119	CbGeAlD
Estradiol—AR—connective tissue—systemic scleroderma	0.000573	0.0116	CbGeAlD
Estradiol—AOX1—digestive system—systemic scleroderma	0.000571	0.0115	CbGeAlD
Estradiol—ESR1—connective tissue—systemic scleroderma	0.000563	0.0114	CbGeAlD
Estradiol—SLCO4A1—lung—systemic scleroderma	0.000559	0.0113	CbGeAlD
Estradiol—ABCC10—digestive system—systemic scleroderma	0.000556	0.0112	CbGeAlD
Estradiol—CYP1B1—smooth muscle tissue—systemic scleroderma	0.000554	0.0112	CbGeAlD
Estradiol—CYP1B1—skin of body—systemic scleroderma	0.000547	0.011	CbGeAlD
Estradiol—AOX1—tendon—systemic scleroderma	0.000544	0.011	CbGeAlD
Estradiol—ABCC10—tendon—systemic scleroderma	0.000529	0.0107	CbGeAlD
Estradiol—AR—smooth muscle tissue—systemic scleroderma	0.000525	0.0106	CbGeAlD
Estradiol—SLCO2B1—digestive system—systemic scleroderma	0.000521	0.0105	CbGeAlD
Estradiol—AR—skin of body—systemic scleroderma	0.000518	0.0105	CbGeAlD
Estradiol—ESR1—smooth muscle tissue—systemic scleroderma	0.000515	0.0104	CbGeAlD
Estradiol—ESR2—lung—systemic scleroderma	0.000496	0.01	CbGeAlD
Estradiol—SLCO2B1—tendon—systemic scleroderma	0.000496	0.01	CbGeAlD
Estradiol—SLCO1A2—digestive system—systemic scleroderma	0.000479	0.00968	CbGeAlD
Estradiol—AOX1—lung—systemic scleroderma	0.000477	0.00964	CbGeAlD
Estradiol—ABCC10—lung—systemic scleroderma	0.000465	0.00938	CbGeAlD
Estradiol—CYP1B1—digestive system—systemic scleroderma	0.000437	0.00883	CbGeAlD
Estradiol—SLCO2B1—lung—systemic scleroderma	0.000435	0.00879	CbGeAlD
Estradiol—ABCB1—blood vessel—systemic scleroderma	0.000434	0.00876	CbGeAlD
Estradiol—CYP1B1—tendon—systemic scleroderma	0.000416	0.0084	CbGeAlD
Estradiol—AR—digestive system—systemic scleroderma	0.000414	0.00836	CbGeAlD
Estradiol—ESR1—digestive system—systemic scleroderma	0.000407	0.00821	CbGeAlD
Estradiol—SLCO1A2—lung—systemic scleroderma	0.0004	0.00808	CbGeAlD
Estradiol—SLC22A3—lung—systemic scleroderma	0.000397	0.00802	CbGeAlD
Estradiol—AR—tendon—systemic scleroderma	0.000394	0.00796	CbGeAlD
Estradiol—CYP1A1—skin of body—systemic scleroderma	0.000387	0.00781	CbGeAlD
Estradiol—CYP2C19—digestive system—systemic scleroderma	0.000384	0.00775	CbGeAlD
Estradiol—CYP1B1—lung—systemic scleroderma	0.000365	0.00738	CbGeAlD
Estradiol—AR—lung—systemic scleroderma	0.000346	0.00698	CbGeAlD
Estradiol—ESR1—lung—systemic scleroderma	0.00034	0.00686	CbGeAlD
Estradiol—CYP1A2—digestive system—systemic scleroderma	0.000313	0.00633	CbGeAlD
Estradiol—CYP1A1—digestive system—systemic scleroderma	0.000309	0.00624	CbGeAlD
Estradiol—CYP3A5—digestive system—systemic scleroderma	0.000302	0.0061	CbGeAlD
Estradiol—CYP2C9—digestive system—systemic scleroderma	0.000298	0.00601	CbGeAlD
Estradiol—ABCG2—lung—systemic scleroderma	0.000272	0.00549	CbGeAlD
Estradiol—CYP1A2—lung—systemic scleroderma	0.000262	0.00529	CbGeAlD
Estradiol—CYP1A1—lung—systemic scleroderma	0.000258	0.00521	CbGeAlD
Estradiol—CYP3A5—lung—systemic scleroderma	0.000252	0.0051	CbGeAlD
Estradiol—CYP3A4—digestive system—systemic scleroderma	0.000227	0.00458	CbGeAlD
Estradiol—ESR1—FOXM1 transcription factor network—CENPB—systemic scleroderma	0.000171	0.074	CbGpPWpGaD
Estradiol—ABCB1—digestive system—systemic scleroderma	0.000161	0.00324	CbGeAlD
Estradiol—ABCB1—lung—systemic scleroderma	0.000134	0.00271	CbGeAlD
Estradiol—AOX1—Effects of Nitric Oxide—NOS3—systemic scleroderma	0.000101	0.0437	CbGpPWpGaD
Estradiol—Weight increased—Prednisone—systemic scleroderma	9.34e-05	0.000397	CcSEcCtD
Estradiol—Pain—Mycophenolic acid—systemic scleroderma	9.33e-05	0.000397	CcSEcCtD
Estradiol—Constipation—Mycophenolic acid—systemic scleroderma	9.33e-05	0.000397	CcSEcCtD
Estradiol—Palpitations—Mycophenolate mofetil—systemic scleroderma	9.32e-05	0.000396	CcSEcCtD
Estradiol—Weight decreased—Prednisone—systemic scleroderma	9.28e-05	0.000395	CcSEcCtD
Estradiol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	9.27e-05	0.000394	CcSEcCtD
Estradiol—Hyperglycaemia—Prednisone—systemic scleroderma	9.26e-05	0.000393	CcSEcCtD
Estradiol—Cough—Mycophenolate mofetil—systemic scleroderma	9.2e-05	0.000391	CcSEcCtD
Estradiol—Dizziness—Captopril—systemic scleroderma	9.17e-05	0.00039	CcSEcCtD
Estradiol—Liver function test abnormal—Methotrexate—systemic scleroderma	9.16e-05	0.000389	CcSEcCtD
Estradiol—Depression—Prednisone—systemic scleroderma	9.12e-05	0.000388	CcSEcCtD
Estradiol—Hypertension—Mycophenolate mofetil—systemic scleroderma	9.11e-05	0.000387	CcSEcCtD
Estradiol—Urticaria—Leflunomide—systemic scleroderma	9.08e-05	0.000386	CcSEcCtD
Estradiol—Abdominal pain—Leflunomide—systemic scleroderma	9.04e-05	0.000384	CcSEcCtD
Estradiol—Body temperature increased—Leflunomide—systemic scleroderma	9.04e-05	0.000384	CcSEcCtD
Estradiol—Acute coronary syndrome—Prednisone—systemic scleroderma	9.02e-05	0.000383	CcSEcCtD
Estradiol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	8.99e-05	0.000382	CcSEcCtD
Estradiol—Myalgia—Mycophenolate mofetil—systemic scleroderma	8.98e-05	0.000382	CcSEcCtD
Estradiol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	8.98e-05	0.000382	CcSEcCtD
Estradiol—Chest pain—Mycophenolate mofetil—systemic scleroderma	8.98e-05	0.000382	CcSEcCtD
Estradiol—Neuropathy peripheral—Prednisone—systemic scleroderma	8.97e-05	0.000381	CcSEcCtD
Estradiol—Myocardial infarction—Prednisone—systemic scleroderma	8.97e-05	0.000381	CcSEcCtD
Estradiol—Breast disorder—Methotrexate—systemic scleroderma	8.97e-05	0.000381	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	8.95e-05	0.000381	CcSEcCtD
Estradiol—Anxiety—Mycophenolate mofetil—systemic scleroderma	8.95e-05	0.00038	CcSEcCtD
Estradiol—Hypersensitivity—Azathioprine—systemic scleroderma	8.92e-05	0.000379	CcSEcCtD
Estradiol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	8.92e-05	0.000379	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	8.92e-05	0.000379	CcSEcCtD
Estradiol—Insomnia—Lisinopril—systemic scleroderma	8.89e-05	0.000378	CcSEcCtD
Estradiol—Discomfort—Mycophenolate mofetil—systemic scleroderma	8.87e-05	0.000377	CcSEcCtD
Estradiol—Paraesthesia—Lisinopril—systemic scleroderma	8.82e-05	0.000375	CcSEcCtD
Estradiol—Vomiting—Captopril—systemic scleroderma	8.82e-05	0.000375	CcSEcCtD
Estradiol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	8.78e-05	0.000373	CcSEcCtD
Estradiol—Dyspnoea—Lisinopril—systemic scleroderma	8.76e-05	0.000372	CcSEcCtD
Estradiol—Rash—Captopril—systemic scleroderma	8.75e-05	0.000372	CcSEcCtD
Estradiol—Dermatitis—Captopril—systemic scleroderma	8.74e-05	0.000372	CcSEcCtD
Estradiol—Somnolence—Lisinopril—systemic scleroderma	8.74e-05	0.000371	CcSEcCtD
Estradiol—Headache—Captopril—systemic scleroderma	8.69e-05	0.000369	CcSEcCtD
Estradiol—Confusional state—Mycophenolate mofetil—systemic scleroderma	8.68e-05	0.000369	CcSEcCtD
Estradiol—Dyspepsia—Lisinopril—systemic scleroderma	8.65e-05	0.000368	CcSEcCtD
Estradiol—Abdominal pain—Mycophenolic acid—systemic scleroderma	8.62e-05	0.000367	CcSEcCtD
Estradiol—Body temperature increased—Mycophenolic acid—systemic scleroderma	8.62e-05	0.000367	CcSEcCtD
Estradiol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	8.61e-05	0.000366	CcSEcCtD
Estradiol—Oedema—Mycophenolate mofetil—systemic scleroderma	8.61e-05	0.000366	CcSEcCtD
Estradiol—Asthma—Methotrexate—systemic scleroderma	8.58e-05	0.000365	CcSEcCtD
Estradiol—Infection—Mycophenolate mofetil—systemic scleroderma	8.55e-05	0.000364	CcSEcCtD
Estradiol—Decreased appetite—Lisinopril—systemic scleroderma	8.54e-05	0.000363	CcSEcCtD
Estradiol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	8.48e-05	0.000361	CcSEcCtD
Estradiol—Fatigue—Lisinopril—systemic scleroderma	8.47e-05	0.00036	CcSEcCtD
Estradiol—Shock—Mycophenolate mofetil—systemic scleroderma	8.47e-05	0.00036	CcSEcCtD
Estradiol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	8.44e-05	0.000359	CcSEcCtD
Estradiol—Hypersensitivity—Leflunomide—systemic scleroderma	8.42e-05	0.000358	CcSEcCtD
Estradiol—Pancreatitis—Methotrexate—systemic scleroderma	8.41e-05	0.000357	CcSEcCtD
Estradiol—Pain—Lisinopril—systemic scleroderma	8.4e-05	0.000357	CcSEcCtD
Estradiol—Constipation—Lisinopril—systemic scleroderma	8.4e-05	0.000357	CcSEcCtD
Estradiol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	8.4e-05	0.000357	CcSEcCtD
Estradiol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	8.36e-05	0.000355	CcSEcCtD
Estradiol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	8.32e-05	0.000354	CcSEcCtD
Estradiol—Diarrhoea—Azathioprine—systemic scleroderma	8.28e-05	0.000352	CcSEcCtD
Estradiol—Haemoglobin—Prednisone—systemic scleroderma	8.26e-05	0.000351	CcSEcCtD
Estradiol—Nausea—Captopril—systemic scleroderma	8.24e-05	0.00035	CcSEcCtD
Estradiol—Abdominal discomfort—Methotrexate—systemic scleroderma	8.22e-05	0.000349	CcSEcCtD
Estradiol—Haemorrhage—Prednisone—systemic scleroderma	8.21e-05	0.000349	CcSEcCtD
Estradiol—Asthenia—Leflunomide—systemic scleroderma	8.2e-05	0.000349	CcSEcCtD
Estradiol—Feeling abnormal—Lisinopril—systemic scleroderma	8.1e-05	0.000344	CcSEcCtD
Estradiol—Pruritus—Leflunomide—systemic scleroderma	8.09e-05	0.000344	CcSEcCtD
Estradiol—Connective tissue disorder—Prednisone—systemic scleroderma	8.07e-05	0.000343	CcSEcCtD
Estradiol—Gastrointestinal pain—Lisinopril—systemic scleroderma	8.03e-05	0.000342	CcSEcCtD
Estradiol—Dizziness—Azathioprine—systemic scleroderma	8.01e-05	0.00034	CcSEcCtD
Estradiol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	7.97e-05	0.000339	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	7.84e-05	0.000333	CcSEcCtD
Estradiol—Photosensitivity reaction—Methotrexate—systemic scleroderma	7.83e-05	0.000333	CcSEcCtD
Estradiol—Asthenia—Mycophenolic acid—systemic scleroderma	7.83e-05	0.000333	CcSEcCtD
Estradiol—Diarrhoea—Leflunomide—systemic scleroderma	7.82e-05	0.000333	CcSEcCtD
Estradiol—Urticaria—Lisinopril—systemic scleroderma	7.81e-05	0.000332	CcSEcCtD
Estradiol—Insomnia—Mycophenolate mofetil—systemic scleroderma	7.79e-05	0.000331	CcSEcCtD
Estradiol—Abdominal pain—Lisinopril—systemic scleroderma	7.77e-05	0.00033	CcSEcCtD
Estradiol—Body temperature increased—Lisinopril—systemic scleroderma	7.77e-05	0.00033	CcSEcCtD
Estradiol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	7.73e-05	0.000329	CcSEcCtD
Estradiol—Pruritus—Mycophenolic acid—systemic scleroderma	7.72e-05	0.000328	CcSEcCtD
Estradiol—Vomiting—Azathioprine—systemic scleroderma	7.7e-05	0.000327	CcSEcCtD
Estradiol—Pneumonia—Methotrexate—systemic scleroderma	7.69e-05	0.000327	CcSEcCtD
Estradiol—Eye disorder—Prednisone—systemic scleroderma	7.68e-05	0.000326	CcSEcCtD
Estradiol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	7.68e-05	0.000326	CcSEcCtD
Estradiol—Somnolence—Mycophenolate mofetil—systemic scleroderma	7.65e-05	0.000325	CcSEcCtD
Estradiol—Infestation NOS—Methotrexate—systemic scleroderma	7.65e-05	0.000325	CcSEcCtD
Estradiol—Infestation—Methotrexate—systemic scleroderma	7.65e-05	0.000325	CcSEcCtD
Estradiol—Rash—Azathioprine—systemic scleroderma	7.63e-05	0.000325	CcSEcCtD
Estradiol—Dermatitis—Azathioprine—systemic scleroderma	7.63e-05	0.000324	CcSEcCtD
Estradiol—Depression—Methotrexate—systemic scleroderma	7.62e-05	0.000324	CcSEcCtD
Estradiol—Flushing—Prednisone—systemic scleroderma	7.62e-05	0.000324	CcSEcCtD
Estradiol—Headache—Azathioprine—systemic scleroderma	7.59e-05	0.000322	CcSEcCtD
Estradiol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	7.58e-05	0.000322	CcSEcCtD
Estradiol—Dizziness—Leflunomide—systemic scleroderma	7.56e-05	0.000321	CcSEcCtD
Estradiol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	7.48e-05	0.000318	CcSEcCtD
Estradiol—Diarrhoea—Mycophenolic acid—systemic scleroderma	7.46e-05	0.000317	CcSEcCtD
Estradiol—Angiopathy—Prednisone—systemic scleroderma	7.45e-05	0.000317	CcSEcCtD
Estradiol—Conjunctivitis—Methotrexate—systemic scleroderma	7.43e-05	0.000316	CcSEcCtD
Estradiol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	7.43e-05	0.000316	CcSEcCtD
Estradiol—Immune system disorder—Prednisone—systemic scleroderma	7.42e-05	0.000315	CcSEcCtD
Estradiol—Pain—Mycophenolate mofetil—systemic scleroderma	7.36e-05	0.000313	CcSEcCtD
Estradiol—Constipation—Mycophenolate mofetil—systemic scleroderma	7.36e-05	0.000313	CcSEcCtD
Estradiol—Haematuria—Methotrexate—systemic scleroderma	7.29e-05	0.00031	CcSEcCtD
Estradiol—Vomiting—Leflunomide—systemic scleroderma	7.27e-05	0.000309	CcSEcCtD
Estradiol—Alopecia—Prednisone—systemic scleroderma	7.26e-05	0.000309	CcSEcCtD
Estradiol—Hypersensitivity—Lisinopril—systemic scleroderma	7.24e-05	0.000308	CcSEcCtD
Estradiol—Hepatobiliary disease—Methotrexate—systemic scleroderma	7.23e-05	0.000307	CcSEcCtD
Estradiol—Dizziness—Mycophenolic acid—systemic scleroderma	7.21e-05	0.000307	CcSEcCtD
Estradiol—Epistaxis—Methotrexate—systemic scleroderma	7.21e-05	0.000307	CcSEcCtD
Estradiol—Rash—Leflunomide—systemic scleroderma	7.21e-05	0.000306	CcSEcCtD
Estradiol—Dermatitis—Leflunomide—systemic scleroderma	7.2e-05	0.000306	CcSEcCtD
Estradiol—Mental disorder—Prednisone—systemic scleroderma	7.2e-05	0.000306	CcSEcCtD
Estradiol—Nausea—Azathioprine—systemic scleroderma	7.19e-05	0.000306	CcSEcCtD
Estradiol—Headache—Leflunomide—systemic scleroderma	7.16e-05	0.000305	CcSEcCtD
Estradiol—Erythema—Prednisone—systemic scleroderma	7.15e-05	0.000304	CcSEcCtD
Estradiol—Malnutrition—Prednisone—systemic scleroderma	7.15e-05	0.000304	CcSEcCtD
Estradiol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	7.09e-05	0.000302	CcSEcCtD
Estradiol—Asthenia—Lisinopril—systemic scleroderma	7.05e-05	0.0003	CcSEcCtD
Estradiol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	7.04e-05	0.000299	CcSEcCtD
Estradiol—Pruritus—Lisinopril—systemic scleroderma	6.95e-05	0.000296	CcSEcCtD
Estradiol—Vomiting—Mycophenolic acid—systemic scleroderma	6.94e-05	0.000295	CcSEcCtD
Estradiol—Haemoglobin—Methotrexate—systemic scleroderma	6.9e-05	0.000293	CcSEcCtD
Estradiol—Rash—Mycophenolic acid—systemic scleroderma	6.88e-05	0.000292	CcSEcCtD
Estradiol—Dermatitis—Mycophenolic acid—systemic scleroderma	6.87e-05	0.000292	CcSEcCtD
Estradiol—Haemorrhage—Methotrexate—systemic scleroderma	6.86e-05	0.000292	CcSEcCtD
Estradiol—Hepatitis—Methotrexate—systemic scleroderma	6.86e-05	0.000292	CcSEcCtD
Estradiol—Urticaria—Mycophenolate mofetil—systemic scleroderma	6.84e-05	0.000291	CcSEcCtD
Estradiol—Headache—Mycophenolic acid—systemic scleroderma	6.83e-05	0.000291	CcSEcCtD
Estradiol—Pharyngitis—Methotrexate—systemic scleroderma	6.81e-05	0.00029	CcSEcCtD
Estradiol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	6.81e-05	0.000289	CcSEcCtD
Estradiol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	6.81e-05	0.000289	CcSEcCtD
Estradiol—Nausea—Leflunomide—systemic scleroderma	6.79e-05	0.000289	CcSEcCtD
Estradiol—Urinary tract disorder—Methotrexate—systemic scleroderma	6.78e-05	0.000288	CcSEcCtD
Estradiol—Urethral disorder—Methotrexate—systemic scleroderma	6.73e-05	0.000286	CcSEcCtD
Estradiol—Diarrhoea—Lisinopril—systemic scleroderma	6.72e-05	0.000286	CcSEcCtD
Estradiol—Ill-defined disorder—Prednisone—systemic scleroderma	6.63e-05	0.000282	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—systemic scleroderma	6.62e-05	0.000281	CcSEcCtD
Estradiol—Agitation—Prednisone—systemic scleroderma	6.57e-05	0.000279	CcSEcCtD
Estradiol—Angioedema—Prednisone—systemic scleroderma	6.53e-05	0.000278	CcSEcCtD
Estradiol—Dizziness—Lisinopril—systemic scleroderma	6.5e-05	0.000276	CcSEcCtD
Estradiol—Erythema multiforme—Methotrexate—systemic scleroderma	6.49e-05	0.000276	CcSEcCtD
Estradiol—Nausea—Mycophenolic acid—systemic scleroderma	6.48e-05	0.000275	CcSEcCtD
Estradiol—Malaise—Prednisone—systemic scleroderma	6.45e-05	0.000274	CcSEcCtD
Estradiol—Vertigo—Prednisone—systemic scleroderma	6.42e-05	0.000273	CcSEcCtD
Estradiol—Eye disorder—Methotrexate—systemic scleroderma	6.42e-05	0.000273	CcSEcCtD
Estradiol—Syncope—Prednisone—systemic scleroderma	6.41e-05	0.000273	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—systemic scleroderma	6.4e-05	0.000272	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—systemic scleroderma	6.37e-05	0.000271	CcSEcCtD
Estradiol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	6.34e-05	0.00027	CcSEcCtD
Estradiol—Loss of consciousness—Prednisone—systemic scleroderma	6.28e-05	0.000267	CcSEcCtD
Estradiol—Vomiting—Lisinopril—systemic scleroderma	6.25e-05	0.000266	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—systemic scleroderma	6.23e-05	0.000265	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—systemic scleroderma	6.2e-05	0.000264	CcSEcCtD
Estradiol—Rash—Lisinopril—systemic scleroderma	6.2e-05	0.000263	CcSEcCtD
Estradiol—Dermatitis—Lisinopril—systemic scleroderma	6.19e-05	0.000263	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—systemic scleroderma	6.19e-05	0.000263	CcSEcCtD
Estradiol—Asthenia—Mycophenolate mofetil—systemic scleroderma	6.18e-05	0.000263	CcSEcCtD
Estradiol—Hypertension—Prednisone—systemic scleroderma	6.17e-05	0.000262	CcSEcCtD
Estradiol—Chills—Methotrexate—systemic scleroderma	6.16e-05	0.000262	CcSEcCtD
Estradiol—Headache—Lisinopril—systemic scleroderma	6.16e-05	0.000262	CcSEcCtD
Estradiol—Pruritus—Mycophenolate mofetil—systemic scleroderma	6.09e-05	0.000259	CcSEcCtD
Estradiol—Arthralgia—Prednisone—systemic scleroderma	6.09e-05	0.000259	CcSEcCtD
Estradiol—Myalgia—Prednisone—systemic scleroderma	6.09e-05	0.000259	CcSEcCtD
Estradiol—Anxiety—Prednisone—systemic scleroderma	6.07e-05	0.000258	CcSEcCtD
Estradiol—Alopecia—Methotrexate—systemic scleroderma	6.07e-05	0.000258	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	6.05e-05	0.000257	CcSEcCtD
Estradiol—Discomfort—Prednisone—systemic scleroderma	6.01e-05	0.000256	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—systemic scleroderma	6.01e-05	0.000256	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—systemic scleroderma	5.98e-05	0.000254	CcSEcCtD
Estradiol—Erythema—Methotrexate—systemic scleroderma	5.98e-05	0.000254	CcSEcCtD
Estradiol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	5.89e-05	0.00025	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—systemic scleroderma	5.85e-05	0.000249	CcSEcCtD
Estradiol—Nausea—Lisinopril—systemic scleroderma	5.84e-05	0.000248	CcSEcCtD
Estradiol—Oedema—Prednisone—systemic scleroderma	5.84e-05	0.000248	CcSEcCtD
Estradiol—Anaphylactic shock—Prednisone—systemic scleroderma	5.84e-05	0.000248	CcSEcCtD
Estradiol—Infection—Prednisone—systemic scleroderma	5.8e-05	0.000246	CcSEcCtD
Estradiol—Back pain—Methotrexate—systemic scleroderma	5.78e-05	0.000246	CcSEcCtD
Estradiol—Shock—Prednisone—systemic scleroderma	5.74e-05	0.000244	CcSEcCtD
Estradiol—Nervous system disorder—Prednisone—systemic scleroderma	5.72e-05	0.000243	CcSEcCtD
Estradiol—Tachycardia—Prednisone—systemic scleroderma	5.7e-05	0.000242	CcSEcCtD
Estradiol—Dizziness—Mycophenolate mofetil—systemic scleroderma	5.69e-05	0.000242	CcSEcCtD
Estradiol—Skin disorder—Prednisone—systemic scleroderma	5.67e-05	0.000241	CcSEcCtD
Estradiol—Hyperhidrosis—Prednisone—systemic scleroderma	5.64e-05	0.00024	CcSEcCtD
Estradiol—ESRRB—Generic Transcription Pathway—SMAD7—systemic scleroderma	5.56e-05	0.0241	CbGpPWpGaD
Estradiol—Ill-defined disorder—Methotrexate—systemic scleroderma	5.54e-05	0.000236	CcSEcCtD
Estradiol—Vomiting—Mycophenolate mofetil—systemic scleroderma	5.47e-05	0.000233	CcSEcCtD
Estradiol—Rash—Mycophenolate mofetil—systemic scleroderma	5.43e-05	0.000231	CcSEcCtD
Estradiol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	5.42e-05	0.000231	CcSEcCtD
Estradiol—Headache—Mycophenolate mofetil—systemic scleroderma	5.39e-05	0.000229	CcSEcCtD
Estradiol—Malaise—Methotrexate—systemic scleroderma	5.39e-05	0.000229	CcSEcCtD
Estradiol—Vertigo—Methotrexate—systemic scleroderma	5.37e-05	0.000228	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	5.32e-05	0.000226	CcSEcCtD
Estradiol—Insomnia—Prednisone—systemic scleroderma	5.28e-05	0.000224	CcSEcCtD
Estradiol—Paraesthesia—Prednisone—systemic scleroderma	5.24e-05	0.000223	CcSEcCtD
Estradiol—Cough—Methotrexate—systemic scleroderma	5.21e-05	0.000222	CcSEcCtD
Estradiol—Dyspepsia—Prednisone—systemic scleroderma	5.14e-05	0.000218	CcSEcCtD
Estradiol—Nausea—Mycophenolate mofetil—systemic scleroderma	5.11e-05	0.000217	CcSEcCtD
Estradiol—Myalgia—Methotrexate—systemic scleroderma	5.09e-05	0.000216	CcSEcCtD
Estradiol—Chest pain—Methotrexate—systemic scleroderma	5.09e-05	0.000216	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—systemic scleroderma	5.09e-05	0.000216	CcSEcCtD
Estradiol—Decreased appetite—Prednisone—systemic scleroderma	5.07e-05	0.000216	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	5.05e-05	0.000215	CcSEcCtD
Estradiol—Fatigue—Prednisone—systemic scleroderma	5.03e-05	0.000214	CcSEcCtD
Estradiol—Discomfort—Methotrexate—systemic scleroderma	5.03e-05	0.000214	CcSEcCtD
Estradiol—Constipation—Prednisone—systemic scleroderma	4.99e-05	0.000212	CcSEcCtD
Estradiol—Confusional state—Methotrexate—systemic scleroderma	4.92e-05	0.000209	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—systemic scleroderma	4.88e-05	0.000207	CcSEcCtD
Estradiol—Infection—Methotrexate—systemic scleroderma	4.85e-05	0.000206	CcSEcCtD
Estradiol—Feeling abnormal—Prednisone—systemic scleroderma	4.81e-05	0.000204	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—systemic scleroderma	4.78e-05	0.000203	CcSEcCtD
Estradiol—Gastrointestinal pain—Prednisone—systemic scleroderma	4.77e-05	0.000203	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—systemic scleroderma	4.74e-05	0.000201	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—systemic scleroderma	4.71e-05	0.0002	CcSEcCtD
Estradiol—Urticaria—Prednisone—systemic scleroderma	4.64e-05	0.000197	CcSEcCtD
Estradiol—Abdominal pain—Prednisone—systemic scleroderma	4.61e-05	0.000196	CcSEcCtD
Estradiol—Body temperature increased—Prednisone—systemic scleroderma	4.61e-05	0.000196	CcSEcCtD
Estradiol—ESR1—FOXM1 transcription factor network—CENPA—systemic scleroderma	4.5e-05	0.0195	CbGpPWpGaD
Estradiol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	4.44e-05	0.000189	CcSEcCtD
Estradiol—Insomnia—Methotrexate—systemic scleroderma	4.41e-05	0.000188	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—systemic scleroderma	4.38e-05	0.000186	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—systemic scleroderma	4.35e-05	0.000185	CcSEcCtD
Estradiol—Somnolence—Methotrexate—systemic scleroderma	4.34e-05	0.000184	CcSEcCtD
Estradiol—Hypersensitivity—Prednisone—systemic scleroderma	4.3e-05	0.000183	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—systemic scleroderma	4.29e-05	0.000182	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—systemic scleroderma	4.24e-05	0.00018	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.21e-05	0.000179	CcSEcCtD
Estradiol—Fatigue—Methotrexate—systemic scleroderma	4.2e-05	0.000179	CcSEcCtD
Estradiol—Asthenia—Prednisone—systemic scleroderma	4.19e-05	0.000178	CcSEcCtD
Estradiol—Pain—Methotrexate—systemic scleroderma	4.17e-05	0.000177	CcSEcCtD
Estradiol—Pruritus—Prednisone—systemic scleroderma	4.13e-05	0.000176	CcSEcCtD
Estradiol—ESRRA—PPARA activates gene expression—CTGF—systemic scleroderma	4.11e-05	0.0178	CbGpPWpGaD
Estradiol—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	4.02e-05	0.0174	CbGpPWpGaD
Estradiol—Feeling abnormal—Methotrexate—systemic scleroderma	4.02e-05	0.000171	CcSEcCtD
Estradiol—Diarrhoea—Prednisone—systemic scleroderma	3.99e-05	0.00017	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.99e-05	0.00017	CcSEcCtD
Estradiol—AR—Regulation of nuclear SMAD2/3 signaling—SMAD7—systemic scleroderma	3.96e-05	0.0171	CbGpPWpGaD
Estradiol—Urticaria—Methotrexate—systemic scleroderma	3.87e-05	0.000165	CcSEcCtD
Estradiol—Dizziness—Prednisone—systemic scleroderma	3.86e-05	0.000164	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—systemic scleroderma	3.86e-05	0.000164	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—systemic scleroderma	3.86e-05	0.000164	CcSEcCtD
Estradiol—Vomiting—Prednisone—systemic scleroderma	3.71e-05	0.000158	CcSEcCtD
Estradiol—Rash—Prednisone—systemic scleroderma	3.68e-05	0.000156	CcSEcCtD
Estradiol—Dermatitis—Prednisone—systemic scleroderma	3.68e-05	0.000156	CcSEcCtD
Estradiol—Headache—Prednisone—systemic scleroderma	3.66e-05	0.000155	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—systemic scleroderma	3.59e-05	0.000153	CcSEcCtD
Estradiol—GPER1—Peptide ligand-binding receptors—EDN1—systemic scleroderma	3.51e-05	0.0152	CbGpPWpGaD
Estradiol—Asthenia—Methotrexate—systemic scleroderma	3.5e-05	0.000149	CcSEcCtD
Estradiol—Nausea—Prednisone—systemic scleroderma	3.47e-05	0.000147	CcSEcCtD
Estradiol—Pruritus—Methotrexate—systemic scleroderma	3.45e-05	0.000147	CcSEcCtD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	3.41e-05	0.0148	CbGpPWpGaD
Estradiol—Diarrhoea—Methotrexate—systemic scleroderma	3.34e-05	0.000142	CcSEcCtD
Estradiol—Dizziness—Methotrexate—systemic scleroderma	3.23e-05	0.000137	CcSEcCtD
Estradiol—Vomiting—Methotrexate—systemic scleroderma	3.1e-05	0.000132	CcSEcCtD
Estradiol—ESRRB—Generic Transcription Pathway—CTGF—systemic scleroderma	3.08e-05	0.0133	CbGpPWpGaD
Estradiol—Rash—Methotrexate—systemic scleroderma	3.08e-05	0.000131	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—systemic scleroderma	3.07e-05	0.000131	CcSEcCtD
Estradiol—Headache—Methotrexate—systemic scleroderma	3.06e-05	0.00013	CcSEcCtD
Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD7—systemic scleroderma	3.05e-05	0.0132	CbGpPWpGaD
Estradiol—ALB—Lipoprotein metabolism—HSPG2—systemic scleroderma	2.97e-05	0.0129	CbGpPWpGaD
Estradiol—CYP1B1—Melatonin metabolism and effects—EDN1—systemic scleroderma	2.94e-05	0.0128	CbGpPWpGaD
Estradiol—Nausea—Methotrexate—systemic scleroderma	2.9e-05	0.000123	CcSEcCtD
Estradiol—AR—Regulation of nuclear SMAD2/3 signaling—COL1A2—systemic scleroderma	2.89e-05	0.0125	CbGpPWpGaD
Estradiol—AR—Androgen receptor signaling pathway—RHOB—systemic scleroderma	2.84e-05	0.0123	CbGpPWpGaD
Estradiol—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	2.77e-05	0.012	CbGpPWpGaD
Estradiol—ESRRB—Gene Expression—SMAD7—systemic scleroderma	2.68e-05	0.0116	CbGpPWpGaD
Estradiol—ESR2—Plasma membrane estrogen receptor signaling—MMP2—systemic scleroderma	2.68e-05	0.0116	CbGpPWpGaD
Estradiol—ESR2—Plasma membrane estrogen receptor signaling—NOS3—systemic scleroderma	2.51e-05	0.0109	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—COL1A2—systemic scleroderma	2.5e-05	0.0108	CbGpPWpGaD
Estradiol—ESRRB—Gene Expression—TNFSF13—systemic scleroderma	2.49e-05	0.0108	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	2.4e-05	0.0104	CbGpPWpGaD
Estradiol—GPER1—Peptide ligand-binding receptors—CCL2—systemic scleroderma	2.4e-05	0.0104	CbGpPWpGaD
Estradiol—ESRRA—Generic Transcription Pathway—SMAD7—systemic scleroderma	2.37e-05	0.0103	CbGpPWpGaD
Estradiol—GPER1—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	2.36e-05	0.0102	CbGpPWpGaD
Estradiol—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—systemic scleroderma	2.31e-05	0.01	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	2.23e-05	0.00968	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—IL13—systemic scleroderma	2.23e-05	0.00967	CbGpPWpGaD
Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—COL1A2—systemic scleroderma	2.22e-05	0.00963	CbGpPWpGaD
Estradiol—NR1I2—Generic Transcription Pathway—SMAD7—systemic scleroderma	2.15e-05	0.00931	CbGpPWpGaD
Estradiol—ESR2—Plasma membrane estrogen receptor signaling—MMP9—systemic scleroderma	2.01e-05	0.00872	CbGpPWpGaD
Estradiol—GPER1—GPCR downstream signaling—RHOB—systemic scleroderma	1.99e-05	0.0086	CbGpPWpGaD
Estradiol—ALB—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	1.97e-05	0.00856	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	1.85e-05	0.00802	CbGpPWpGaD
Estradiol—CYP1A1—Melatonin metabolism and effects—EDN1—systemic scleroderma	1.81e-05	0.00786	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—RHOB—systemic scleroderma	1.8e-05	0.00781	CbGpPWpGaD
Estradiol—GPER1—GPCR ligand binding—EDN1—systemic scleroderma	1.79e-05	0.00777	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—CSF1—systemic scleroderma	1.73e-05	0.00751	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	1.72e-05	0.00746	CbGpPWpGaD
Estradiol—GPER1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	1.61e-05	0.00698	CbGpPWpGaD
Estradiol—ALB—Platelet degranulation—SELP—systemic scleroderma	1.54e-05	0.00667	CbGpPWpGaD
Estradiol—ESR2—Generic Transcription Pathway—SMAD7—systemic scleroderma	1.51e-05	0.00655	CbGpPWpGaD
Estradiol—CYP2C19—Melatonin metabolism and effects—EDN1—systemic scleroderma	1.48e-05	0.00643	CbGpPWpGaD
Estradiol—ESRRB—Gene Expression—CTGF—systemic scleroderma	1.48e-05	0.00642	CbGpPWpGaD
Estradiol—ALB—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	1.47e-05	0.00636	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—IL13—systemic scleroderma	1.46e-05	0.00633	CbGpPWpGaD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.46e-05	0.00631	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	1.4e-05	0.00609	CbGpPWpGaD
Estradiol—ABCG2—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	1.39e-05	0.00601	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—SMAD7—systemic scleroderma	1.38e-05	0.00597	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—EDN1—systemic scleroderma	1.35e-05	0.00586	CbGpPWpGaD
Estradiol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—systemic scleroderma	1.35e-05	0.00585	CbGpPWpGaD
Estradiol—ESR1—FOXM1 transcription factor network—MMP2—systemic scleroderma	1.32e-05	0.00574	CbGpPWpGaD
Estradiol—ESRRA—Generic Transcription Pathway—CTGF—systemic scleroderma	1.31e-05	0.00569	CbGpPWpGaD
Estradiol—ESR1—Plasma membrane estrogen receptor signaling—NOS3—systemic scleroderma	1.26e-05	0.00548	CbGpPWpGaD
Estradiol—GPER1—GPCR ligand binding—CCL2—systemic scleroderma	1.23e-05	0.00531	CbGpPWpGaD
Estradiol—NR1I2—Generic Transcription Pathway—CTGF—systemic scleroderma	1.19e-05	0.00515	CbGpPWpGaD
Estradiol—CYP1A2—Melatonin metabolism and effects—EDN1—systemic scleroderma	1.16e-05	0.00501	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—SMAD7—systemic scleroderma	1.14e-05	0.00495	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—MMP1—systemic scleroderma	1.14e-05	0.00493	CbGpPWpGaD
Estradiol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	1.13e-05	0.0049	CbGpPWpGaD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.1e-05	0.00478	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—RHOB—systemic scleroderma	1.06e-05	0.00461	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—TNFSF13—systemic scleroderma	1.06e-05	0.00461	CbGpPWpGaD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	1.06e-05	0.00457	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—SMAD7—systemic scleroderma	1.03e-05	0.00448	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—IL13—systemic scleroderma	1.03e-05	0.00445	CbGpPWpGaD
Estradiol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	1.03e-05	0.00445	CbGpPWpGaD
Estradiol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—systemic scleroderma	1.01e-05	0.0044	CbGpPWpGaD
Estradiol—GPER1—GPCR downstream signaling—EDN1—systemic scleroderma	1.01e-05	0.00439	CbGpPWpGaD
Estradiol—ESR1—ATF-2 transcription factor network—MMP2—systemic scleroderma	1.01e-05	0.00437	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—HSPG2—systemic scleroderma	1e-05	0.00435	CbGpPWpGaD
Estradiol—AR—Generic Transcription Pathway—SMAD7—systemic scleroderma	9.89e-06	0.00429	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CSK—systemic scleroderma	9.7e-06	0.0042	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—TNFSF13—systemic scleroderma	9.61e-06	0.00417	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—CCL2—systemic scleroderma	9.25e-06	0.00401	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—EDN1—systemic scleroderma	9.2e-06	0.00399	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	9.19e-06	0.00398	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	9.11e-06	0.00395	CbGpPWpGaD
Estradiol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	8.79e-06	0.00381	CbGpPWpGaD
Estradiol—CYP1A1—PPARA activates gene expression—CTGF—systemic scleroderma	8.74e-06	0.00379	CbGpPWpGaD
Estradiol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	8.55e-06	0.00371	CbGpPWpGaD
Estradiol—ESR2—Generic Transcription Pathway—CTGF—systemic scleroderma	8.35e-06	0.00362	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	8.26e-06	0.00358	CbGpPWpGaD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	8.2e-06	0.00355	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	7.98e-06	0.00346	CbGpPWpGaD
Estradiol—ESR1—Leptin signaling pathway—NOS3—systemic scleroderma	7.8e-06	0.00338	CbGpPWpGaD
Estradiol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic scleroderma	7.71e-06	0.00334	CbGpPWpGaD
Estradiol—ESR1—Generic Transcription Pathway—SMAD7—systemic scleroderma	7.62e-06	0.0033	CbGpPWpGaD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	7.5e-06	0.00325	CbGpPWpGaD
Estradiol—AOX1—Disease—SMAD7—systemic scleroderma	7.36e-06	0.00319	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	7.35e-06	0.00319	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	7.32e-06	0.00317	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—SMAD7—systemic scleroderma	7.28e-06	0.00315	CbGpPWpGaD
Estradiol—ALB—Vitamin B12 Metabolism—CCL2—systemic scleroderma	7.19e-06	0.00312	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	6.83e-06	0.00296	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	6.8e-06	0.00295	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—TNFSF13—systemic scleroderma	6.76e-06	0.00293	CbGpPWpGaD
Estradiol—AOX1—Disease—TGFBI—systemic scleroderma	6.73e-06	0.00292	CbGpPWpGaD
Estradiol—ESR1—Leptin signaling pathway—IL1B—systemic scleroderma	6.64e-06	0.00288	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—MMP9—systemic scleroderma	6.61e-06	0.00287	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	6.5e-06	0.00282	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—HSPG2—systemic scleroderma	6.49e-06	0.00281	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	6.46e-06	0.0028	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	6.42e-06	0.00278	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	6.38e-06	0.00276	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—CTGF—systemic scleroderma	6.32e-06	0.00274	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—CCL2—systemic scleroderma	6.29e-06	0.00273	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	6.15e-06	0.00266	CbGpPWpGaD
Estradiol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	5.89e-06	0.00255	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—CCL2—systemic scleroderma	5.85e-06	0.00254	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	5.81e-06	0.00252	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.78e-06	0.0025	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—CTGF—systemic scleroderma	5.72e-06	0.00248	CbGpPWpGaD
Estradiol—ESR1—Regulation of Telomerase—TGFB1—systemic scleroderma	5.58e-06	0.00242	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	5.57e-06	0.00241	CbGpPWpGaD
Estradiol—AR—Generic Transcription Pathway—CTGF—systemic scleroderma	5.47e-06	0.00237	CbGpPWpGaD
Estradiol—ALB—Vitamin B12 Metabolism—IL1B—systemic scleroderma	5.46e-06	0.00236	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—TGFB1—systemic scleroderma	5.45e-06	0.00236	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—EDN1—systemic scleroderma	5.44e-06	0.00236	CbGpPWpGaD
Estradiol—AOX1—Disease—HSPG2—systemic scleroderma	5.37e-06	0.00233	CbGpPWpGaD
Estradiol—AOX1—Disease—CSK—systemic scleroderma	5.18e-06	0.00225	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	5.05e-06	0.00219	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.03e-06	0.00218	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.94e-06	0.00214	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—CTGF—systemic scleroderma	4.91e-06	0.00213	CbGpPWpGaD
Estradiol—AOX1—Disease—CD247—systemic scleroderma	4.87e-06	0.00211	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	4.84e-06	0.0021	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	4.79e-06	0.00208	CbGpPWpGaD
Estradiol—AR—Gene Expression—SMAD7—systemic scleroderma	4.76e-06	0.00206	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—CCL2—systemic scleroderma	4.65e-06	0.00201	CbGpPWpGaD
Estradiol—AOX1—Metabolism—HSPG2—systemic scleroderma	4.5e-06	0.00195	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—IL1B—systemic scleroderma	4.44e-06	0.00192	CbGpPWpGaD
Estradiol—AR—Gene Expression—TNFSF13—systemic scleroderma	4.43e-06	0.00192	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.38e-06	0.0019	CbGpPWpGaD
Estradiol—ESR1—Generic Transcription Pathway—CTGF—systemic scleroderma	4.21e-06	0.00183	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	4.14e-06	0.0018	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—CTGF—systemic scleroderma	4.02e-06	0.00174	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.81e-06	0.00165	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.74e-06	0.00162	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CCL2—systemic scleroderma	3.72e-06	0.00161	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—SMAD7—systemic scleroderma	3.67e-06	0.00159	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—IL1B—systemic scleroderma	3.53e-06	0.00153	CbGpPWpGaD
Estradiol—ALB—Hemostasis—SELP—systemic scleroderma	3.52e-06	0.00153	CbGpPWpGaD
Estradiol—UGT1A1—NRF2 pathway—TGFB1—systemic scleroderma	3.49e-06	0.00151	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—TNFSF13—systemic scleroderma	3.41e-06	0.00148	CbGpPWpGaD
Estradiol—AOX1—Metabolism—CTGF—systemic scleroderma	3.41e-06	0.00148	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	3.37e-06	0.00146	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—NOS3—systemic scleroderma	3.31e-06	0.00144	CbGpPWpGaD
Estradiol—ALB—Hemostasis—RHOB—systemic scleroderma	3.29e-06	0.00142	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—HSPG2—systemic scleroderma	3.27e-06	0.00142	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	3.22e-06	0.0014	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—HSPG2—systemic scleroderma	3.21e-06	0.00139	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.17e-06	0.00137	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.1e-06	0.00134	CbGpPWpGaD
Estradiol—ALB—Hemostasis—CSK—systemic scleroderma	2.99e-06	0.0013	CbGpPWpGaD
Estradiol—ALB—Platelet degranulation—TGFB1—systemic scleroderma	2.96e-06	0.00128	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.84e-06	0.00123	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.82e-06	0.00122	CbGpPWpGaD
Estradiol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	2.82e-06	0.00122	CbGpPWpGaD
Estradiol—ALB—Hemostasis—ITGAM—systemic scleroderma	2.81e-06	0.00122	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—MMP9—systemic scleroderma	2.66e-06	0.00115	CbGpPWpGaD
Estradiol—AR—Gene Expression—CTGF—systemic scleroderma	2.63e-06	0.00114	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	2.62e-06	0.00113	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—HSPG2—systemic scleroderma	2.57e-06	0.00111	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.53e-06	0.0011	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—CTGF—systemic scleroderma	2.48e-06	0.00108	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	2.44e-06	0.00106	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—CTGF—systemic scleroderma	2.44e-06	0.00106	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—HSPG2—systemic scleroderma	2.4e-06	0.00104	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SMAD7—systemic scleroderma	2.39e-06	0.00103	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.35e-06	0.00102	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.31e-06	0.001	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—HSPG2—systemic scleroderma	2.24e-06	0.00097	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—HSPG2—systemic scleroderma	2.2e-06	0.000953	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—TGFB1—systemic scleroderma	2.19e-06	0.000949	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.15e-06	0.000932	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—NOS3—systemic scleroderma	2.14e-06	0.000927	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.14e-06	0.000927	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—HSPG2—systemic scleroderma	2.04e-06	0.000883	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—CTGF—systemic scleroderma	2.03e-06	0.000879	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—HSPG2—systemic scleroderma	2.02e-06	0.000875	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—HSPG2—systemic scleroderma	2.02e-06	0.000873	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.97e-06	0.000855	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CTGF—systemic scleroderma	1.95e-06	0.000845	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.92e-06	0.000832	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—HSPG2—systemic scleroderma	1.88e-06	0.000814	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RHOB—systemic scleroderma	1.85e-06	0.0008	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CTGF—systemic scleroderma	1.82e-06	0.000788	CbGpPWpGaD
Estradiol—AOX1—Disease—NOS3—systemic scleroderma	1.77e-06	0.000767	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.75e-06	0.000759	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HSPG2—systemic scleroderma	1.74e-06	0.000754	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CTGF—systemic scleroderma	1.7e-06	0.000735	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CSK—systemic scleroderma	1.68e-06	0.000728	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CTGF—systemic scleroderma	1.67e-06	0.000722	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CTGF—systemic scleroderma	1.54e-06	0.000669	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CTGF—systemic scleroderma	1.53e-06	0.000663	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CTGF—systemic scleroderma	1.53e-06	0.000662	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.5e-06	0.000648	CbGpPWpGaD
Estradiol—AOX1—Metabolism—NOS3—systemic scleroderma	1.48e-06	0.000643	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—HSPG2—systemic scleroderma	1.46e-06	0.000632	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CTGF—systemic scleroderma	1.42e-06	0.000617	CbGpPWpGaD
Estradiol—ALB—Hemostasis—MMP1—systemic scleroderma	1.41e-06	0.000611	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—HSPG2—systemic scleroderma	1.38e-06	0.000597	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.31e-06	0.000568	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.29e-06	0.00056	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—HSPG2—systemic scleroderma	1.26e-06	0.000548	CbGpPWpGaD
Estradiol—ALB—Metabolism—HSPG2—systemic scleroderma	1.26e-06	0.000545	CbGpPWpGaD
Estradiol—AOX1—Disease—TGFB1—systemic scleroderma	1.17e-06	0.000507	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—HSPG2—systemic scleroderma	1.13e-06	0.000489	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CTGF—systemic scleroderma	1.11e-06	0.000479	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.1e-06	0.000477	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—NOS3—systemic scleroderma	1.08e-06	0.000468	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—NOS3—systemic scleroderma	1.06e-06	0.000459	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CTGF—systemic scleroderma	1.04e-06	0.000453	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—HSPG2—systemic scleroderma	1.03e-06	0.000446	CbGpPWpGaD
Estradiol—ALB—Hemostasis—NOS3—systemic scleroderma	1.02e-06	0.000443	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CTGF—systemic scleroderma	9.58e-07	0.000415	CbGpPWpGaD
Estradiol—ALB—Metabolism—CTGF—systemic scleroderma	9.52e-07	0.000413	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EDN1—systemic scleroderma	9.42e-07	0.000408	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—HSPG2—systemic scleroderma	8.79e-07	0.000381	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CTGF—systemic scleroderma	8.55e-07	0.000371	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—NOS3—systemic scleroderma	8.48e-07	0.000368	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CTGF—systemic scleroderma	8.34e-07	0.000362	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—NOS3—systemic scleroderma	7.92e-07	0.000343	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CTGF—systemic scleroderma	7.8e-07	0.000338	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—NOS3—systemic scleroderma	7.38e-07	0.00032	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—NOS3—systemic scleroderma	7.26e-07	0.000314	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HSPG2—systemic scleroderma	6.78e-07	0.000294	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TGFB1—systemic scleroderma	6.76e-07	0.000293	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—NOS3—systemic scleroderma	6.72e-07	0.000291	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CTGF—systemic scleroderma	6.66e-07	0.000289	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—NOS3—systemic scleroderma	6.66e-07	0.000289	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—NOS3—systemic scleroderma	6.65e-07	0.000288	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL2—systemic scleroderma	6.44e-07	0.000279	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—NOS3—systemic scleroderma	6.2e-07	0.000269	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NOS3—systemic scleroderma	5.74e-07	0.000249	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CTGF—systemic scleroderma	5.14e-07	0.000223	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—NOS3—systemic scleroderma	4.81e-07	0.000209	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MMP9—systemic scleroderma	4.61e-07	0.0002	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—NOS3—systemic scleroderma	4.55e-07	0.000197	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NOS3—systemic scleroderma	4.17e-07	0.000181	CbGpPWpGaD
Estradiol—ALB—Metabolism—NOS3—systemic scleroderma	4.15e-07	0.00018	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TGFB1—systemic scleroderma	3.8e-07	0.000165	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NOS3—systemic scleroderma	3.72e-07	0.000161	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NOS3—systemic scleroderma	3.63e-07	0.000157	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NOS3—systemic scleroderma	3.39e-07	0.000147	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NOS3—systemic scleroderma	2.9e-07	0.000126	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NOS3—systemic scleroderma	2.24e-07	9.7e-05	CbGpPWpGaD
